- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
National Institute of Allergy and Infectious Disease Awards Grant to ResVita Bio
ResVita will use the money to develop a treatment for severe atopic dermatitis.
ResVita Bio announced that it has been awarded a $250,000 grant from the National Institute of Allergy and Infectious Disease (NIAID). The grant, titled the Phase 1 Small Business Innovation Research grant, will be used to develop a cell therapy for treating severe atopic dermatitis.
In a press release, ResVita Bio’s CEO Amin Zargar, PhD, said, “Within a year, we have been honored to receive two innovation grants from the NIH to develop therapies for both Netherton Syndrome, an orphan disease, and severe atopic dermatitis through our topical cell therapy approach. This is in addition to our Rare Pediatric Disease Designation for Netherton Syndrome from the FDA, setting the stage for the entry of our therapy into the clinic in 2025."
The treatment, called RVB-101, utilizes genetically engineered cells that are applied to the skin using a topical moisturizer. The cells then colonize the skin and repair the epidermal barrier and alleviate inflammation.
Source
(September 18, 2023); PR Newswire; ResVita Bio Receives NIH Grant to Develop Breakthrough Treatment for Severe Atopic Dermatitis; https://www.prnewswire.com/news-releases/resvita-bio-receives-nih-grant-to-develop-breakthrough-treatment-for-severe-atopic-dermatitis-301929130.html
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
